November 10, 2007 12:00 AM
Merck & Co.'s agreement to pay $4.85 billion to resolve lawsuits over its Vioxx painkiller offers certainty of a payday to thousands of plaintiffs who no longer must prove the drug caused their heart attacks or strokes.
November 10, 2007 12:00 AM
If approved by claimants, Merck deal could end roughly 50,000 lawsuits. Even when it was winning most Vioxx lawsuits in the courtroom, the maker of the withdrawn painkiller was losing in other areas.
November 10, 2007 12:00 AM
Merck & Co. said Friday it will pay $4.85 billion to end thousands of lawsuits over its painkiller Vioxx in what is believed to be the largest drug settlement ever.
November 9, 2007 12:00 AM
Merck & Co. said Friday it will pay $4.85 billion to end thousands of lawsuits over its painkiller Vioxx in what is believed to be the largest drug settlement ever.
November 9, 2007 12:00 AM
Company officials estimated the deal, if accepted, would end 45,000 to 50,000 personal injury lawsuits involving U.S. Vioxx users who suffered a heart attack or ischemic stroke, the type in which blood flow to the brain is blocked.
November 9, 2007 12:00 AM
Plaintiffs' lawyers this morning announced that Merck & Co. has agreed to pay $4.85 billion to settle the majority of claims over injuries linked to its Vioxx painkiller.
November 9, 2007 12:00 AM
The maker of the painkiller Vioxx has agreed to pay more than $4.8 billion to settle thousands of lawsuits in one of the largest civil cases ever.
November 9, 2007 12:00 AM
Merck & Co. announced Friday that it will pay $4.85 billion to settle as claims by as many as 47,000 groups of plaintiffs over injuries linked to its blockbuster Vioxx painkiller.
November 9, 2007 12:00 AM
Montgomery law firm Beasley, Allen is on the winning side of a $4.85 billion settlement for users of the painkiller Vioxx who claim they were harmed by the drug.
November 9, 2007 12:00 AM
Wanting to move on from the legacy of its deadly painkiller, the maker of Vioxx, Merck & Co. this morning signed an agreement to pay $4.85 billion to settle the outstanding individual product liability claims against the drug.